NuChem Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- NuChem Therapeutics's estimated annual revenue is currently $7.5M per year.
- NuChem Therapeutics's estimated revenue per employee is $49,342
Employee Data
- NuChem Therapeutics has 152 Employees.
- NuChem Therapeutics grew their employee count by 17% last year.
NuChem Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Director, Biology | Reveal Email/Phone |
2 | Scientist | Reveal Email/Phone |
NuChem Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $3.5M | 51 | 6% | N/A | N/A |
#2 | $15M | 332 | N/A | N/A | N/A |
#3 | $3.5M | 18 | -5% | N/A | N/A |
#4 | $3.5M | 20 | -29% | N/A | N/A |
#5 | N/A | 1949 | -7% | N/A | N/A |
#6 | $7.5M | 122 | 20% | N/A | N/A |
#7 | $15M | 75 | -3% | N/A | N/A |
#8 | $15M | 135 | 2% | N/A | N/A |
#9 | $15M | 191 | N/A | N/A | N/A |
#10 | N/A | 6 | N/A | N/A | N/A |
What Is NuChem Therapeutics?
NuChem Therapeutics is a Medicinal Chemistry contract research organization located in Montreal, Quebec, Canada. We offer a variety of services to support the biotech and pharmaceuticals industries to help identify and optimise pre-clinical candidates in the area of small molecule drug discovery. All members of our team have years of experience in preclinical drug discovery in the pharmaceutical industry (former Merck Frosst Canada scientists). We specialize in the art of medicinal chemistry and drug discovery biology and can provide custom synthesis of compounds, structure-activity-relationship (SAR) design, DMPK services, computational drug design and assay development to move your project forward quickly and efficiently. Our goal at NuChem Therapeutics is to become your first choice CRO partner by providing world class, cost-efficient and rapid-turnaround medicinal chemistry expertise with a strong customer focus.
keywords:N/AN/A
Total Funding
152
Number of Employees
$7.5M
Revenue (est)
17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
NuChem Therapeutics News
... lead compound with therapeutic potential, play a crucial role in the overall success of a drug candidate in both preclinical and clinical studies.
CPE Media News (2/24/2019) – AmorChem L.P., an early stage life sciences venture capital fund, has sold NuChem Therapeutics Inc. to ...
MONTREAL--(BUSINESS WIRE)--NuChem Therapeutics Inc., a drug discovery and development contract research organization (CRO) located ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $30.1M | 152 | 26% | N/A |
#2 | $35.1M | 152 | 6% | N/A |
#3 | $35.1M | 152 | 9% | N/A |
#4 | $34.5M | 153 | -11% | N/A |
#5 | $45.4M | 153 | 1% | N/A |